Acarbose
Acarbose is an alpha-glucosidase inhibitor used in type 2 diabetes. It acts in the intestine to delay the breakdown and absorption of carbohydrates after food.
Key points
- Acarbose inhibits intestinal alpha-glucosidase enzymes.
- Its effect is centred on post-meal glucose rises rather than stimulating insulin release.
Precose gives the catalogue a direct brand-to-ingredient connection for acarbose and type 2 diabetes. Gastrointestinal effects such as flatulence and diarrhoea follow from undigested carbohydrate reaching the lower bowel, making them particularly connected to this medicine’s site of action.